Nivolumab May Induce Promising Efficacy Outcomes in Certain Gynecologic Malignancies

Immunotherapy could replace chemotherapy in some patients with recurrent/metastatic cervical and vaginal or vulvar cancers.

Source: CancerNetwork - September 23, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news